1-5 of 5
Deborah M. Martinez-Banos
Close
Sort by
Journal Articles

Comparison of Daratumumab Plus Bortezomib, Melphalan, and Prednisone (D-VMP) with Standard of Care for Patients from Latin America with Newly Diagnosed Multiple Myeloma (NDMM) Who Were Transplant Ineligible: A Propensity Score Matching Analysis

Vania T.M. Hungria, MD PhD, Deborah M. Martinez-Banos, Maria-Victoria Mateos, Meletios A. Dimopoulos, MD, Michele Cavo, Bart Heeg, PhD, Annette Lam, Gerardo Machnicki, Jianming He, PhD, Mariana Fernandez
Journal: Blood
Blood (2019) 134 (Supplement_1): 2143.
https://doi.org/10.1182/blood-2019-123557
Published: 2019
Journal Articles

Impact of Osseous and Non-Osseous Extramedullary Disease in Multiple Myeloma: Clinical Characteristics and Outcomes in a Latin American Population

Cesar Vargas-Serafin, MD, Aldo A Acosta-Medina, MS, Juan Rangel-Patiño, MD, Daniela Perez-Samano, MD, Deborah M. Martinez-Banos, Christianne Bourlon, MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 5527.
https://doi.org/10.1182/blood-2019-128791
Published: 2019
Journal Articles

Real-World Determinants of Survival in Multiple Myeloma: Experience of a Referral Center in Latin America

Aldo A Acosta-Medina, MS, Cesar Vargas-Serafin, MD, Deborah M. Martinez-Banos, Christianne Bourlon, MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 5533.
https://doi.org/10.1182/blood-2019-131957
Published: 2019
Journal Articles

Treatment Patterns and Survival Outcomes in Latin American Patients with Newly Diagnosed Multiple Myeloma: A Retrospective Medical Chart Review Study, 2008-2016

Vania T M Hungria, MD PhD, Deborah M. Martinez-Banos, Christian Ramos Penafiel, Carlos Eduardo Miguel, Jorge Vela-Ojeda, MD PhD, Guillermina Remaggi, Fernando Barroso Duarte, Carmen Cao, Maria Silvana Cugliari, Telma Santos, Eduardo Santos, Gerardo Machnicki, Jennifer Hsiang-Ling Lin, Yen-Wen Chen, Paula Barreyro
Journal: Blood
Blood (2017) 130 (Supplement 1): 2113.
https://doi.org/10.1182/blood.V130.Suppl_1.2113.2113
Published: 2017
Journal Articles

Prophylactic Low-Dose Aspirin Is Effective as Antithrombotic Therapy in Patients Receiving Combination Thalidomide or Lenalidomide.

Ruben Niesvizky, MD, Deborah M. Martinez-Banos, MD, Udi Y. Gelbshtein, Hearn J. Cho, MD, PhD, Roger N. Pearse, MD, PhD, Faiza Zafar, RPAC, Karen Pekle, NP, Richard Furman, MD, John P. Leonard, MD, Morton Coleman, MD
Journal: Blood
Blood (2005) 106 (11): 3454.
https://doi.org/10.1182/blood.V106.11.3454.3454
Published: 2005